Document:

NET2WIRELESS CORPORATION

                            STOCK PURCHASE AGREEMENT

     THIS  STOCK PURCHASE AGREEMENT is made as of the 26th day of July, 2000, by
and  among NET2WIRELESS CORPORATION, a Delaware corporation (the "Company"), and
NEXTEL  FINANCE  COMPANY,  a  Delaware  corporation  ("NFC")

     WHEREAS, the Company desires to sell to NFC or to an indirect subsidiary of
Nextel  Communications  Inc.  ("NCI")  that  is  designated  by NFC (NFC or such
designated  subsidiary,  the  "Investor")  and  the Investor desires to purchase
shares  of  Series  B  Preferred Stock, par value $.01 per share, of the Company
(the "Series B Preferred Stock") upon the terms and conditions set forth in this
agreement;

                          W  I  T  N  E  S  S  E  T  H:

     NOW,  THEREFORE,  THE  PARTIES  HEREBY  AGREE  AS  FOLLOWS:

     1.     Purchase  and  Sale  of  Stock.

(a)     Purchase  and  Sale.  Subject  to  the terms and conditions of this
Agreement, the parties hereby agree that, at the Closing (as defined below), the
Company  will sell and issue to the Investor, and the Investor will purchase and
accept,  one  million  (1,000,000)  shares  of  Series  B  Preferred  Stock (the
"Shares")  at  a  purchase  price  per  share  of  $32.00.

(b)     Closing.  The  purchase  and sale of the Shares contemplated hereby
shall  take  place  at  the  offices  of  Brobeck,  Phleger & Harrison LLP, 1633
Broadway,  47th  Floor,  New  York,  New York 10019 at 10:00 a.m. on October 15,
2000,  or  at such other time and place as the Company and the Investor mutually
agree  (which  time and place are designated as the "Closing").  At the Closing,
the  Company  shall  deliver  to  the  Investor  certificate(s) representing the
Shares,  and  the  Investor  shall deliver to the Company the aggregate purchase
price  of  $32,000,000  by  wire  transfer  of  immediately  available  funds.

(c)     Adjustments Upon Changes in Capitalization.  (i) The number and class of
the  Shares  and the purchase price per share shall all be equitably adjusted to
reflect  any  change in the Series B Preferred Stock by reason of a stock split,
reverse  stock  split, stock dividend or like capital adjustment or to reflect a
conversion  or  exchange  of  the  stock  for  other securities as a result of a
merger,  consolidation  or  reorganization; and (ii) in the event of a mandatory
conversion  of  the  Series B Preferred Stock to common stock of the Company, or
the  merger pursuant to the Agreement between Sensar Corporation and the Company
dated  December  8,  1999 is consummated, the earlier to occur, the purchase and
sale  contemplated  hereby  shall be a purchase and sale for common stock of the
Company  on the same terms as set forth in this Agreement for Series B Preferred
Stock.  In  the event of a mandatory conversion pursuant to the foregoing clause
(ii)  the  Company  will  deliver  to  the  Investor a certificate detailing the
adjustment  or  the  conversion  as  the  case  may  be  and  the  basis for any
calculations.

<PAGE>

(d)     Completion  of  Disclosure  Schedules.  The  Investor  agrees  and
acknowledges  that  the  Company's  disclosure  schedules  attached  hereto (the
"Schedules") are incomplete and the Company's representations and warranties set
forth  in  Section  2  below may be further qualified thereby and remain subject
thereto.  Within  thirty  (30) days following the date hereof, the Company shall
furnish  to  the  Investor a complete and final set of the Schedules, which, for
purposes of this Agreement and the transactions contemplated hereby, the parties
agree  shall  replace  the Schedules originally attached hereto and be deemed to
have  been  delivered  on  the  date  hereof.

     2.     Representations  and  Warranties of the Company.  The Company hereby
represents  and  warrants  to  the  Investor  that,  except  as set forth on the
Schedules  identifying  the relevant subparagraph hereof, which exceptions shall
be  deemed  to  be  representations  and  warranties  as  if  made  hereunder:

     2.1     Organization,  Good  Standing  and Qualification.  The Company is a
corporation duly organized, validly existing and in good standing under the laws
of  the State of Delaware and has all requisite corporate power and authority to
carry  on  its  business  as now conducted and as proposed to be conducted.  The
Company  is  duly qualified to transact business and is in good standing in each
jurisdiction  in  which  the failure to so qualify would have a material adverse
effect  on  its  business  or  properties.

     2.2     Capitalization  and  Voting  Rights.  The authorized capital of the
Company  consists  of:

(a)     Preferred  Stock.  10,000,000  shares of Preferred Stock, par value
$.01  (the  "Preferred  Stock"),  of which 2,000,000 shares have been designated
Series  A  Preferred  Stock,  1,041,140  of  which  are  issued and outstanding.
Immediately  prior  to  the  Closing,  1,000,000  shares  of  Preferred  will be
designated  Series  B  Preferred  Stock,  which  may  be  sold  pursuant to this
Agreement.  The  rights,  privileges  and  preferences of the Series B Preferred
Stock  will be as stated in the form of the Company's Certificate of Designation
attached  hereto  as  Exhibit  A  to  be filed immediately prior to the Closing.

(b)     Common  Stock.  50,000,000  shares  of common stock, par value $.01
per  share  ("Common  Stock"),  of  which  17,253,920  shares  are  issued  and
outstanding.

(c)     The  outstanding shares of Common Stock and Series A Preferred Stock are
owned  by  the  persons  and in the numbers specified on Schedule 2.2(c) hereof.

(d)     The  outstanding shares of Common Stock and Series A Preferred Stock are
all  duly  and  validly authorized and issued, fully paid and nonassessable, and
were  issued  in accordance with the registration or qualification provisions of
the  Securities  Act  of  1933,  as  amended (the "Act"), and any relevant state
securities  laws,  or  pursuant  to valid exemptions therefrom. No holder of any
capital  stock  of  the  Company  has  any put rescission or similar rights with
respect  to  his,  her  or  its  shares.

<PAGE>

(e)     The  Company has reserved 14,766,649 shares of its Common Stock for
purchase  upon  exercise of options and warrants.  The Company is not a party or
subject  to  any  agreement  or understanding, and, to the best of the Company's
knowledge,  there  is  no  agreement or understanding between any persons and/or
entities,  which  affects or relates to the voting or giving of written consents
with  respect  to  any  security  or  by  a  director  of the Company, except as
specified  on  Schedule  2.2(e).

(f)     Schedule  2.2(f)  lists  (i)  all  outstanding  warrants,  options,
agreements,  convertible securities or other commitments or instruments pursuant
to  which  the Company is or may become obligated to issue or sell any shares of
its  capital  stock or other securities and (ii) the number of shares of capital
stock  or  other  securities  the  Company may become obligated to issue or sell
thereunder.

     2.3     Subsidiaries.  Except  for  Net2Wireless  Israel Ltd., Fastnet.com,
Inc.  and  Vintage  Global  Inc., the Company does not presently own or control,
directly  or  indirectly, any interest in any other corporation, association, or
other  business  entity.  The Company is not a participant in any joint venture,
partnership,  or  similar  arrangement.

     2.4     Authorization.  All  corporate  action  on the part of the Company,
its  officers,  directors  and  stockholders  necessary  for  the authorization,
execution  and delivery of this Agreement, the performance of all obligations of
the  Company  hereunder,  and  the  authorization,  issuance (or reservation for
issuance), sale and delivery of the Series B Preferred Stock that is the subject
of  this Agreement and the Common Stock issuable upon conversion of the Series B
Preferred  Stock,  has been taken or will be taken prior to the Closing, if any,
of  the  purchase  of  the  shares, and this Agreement constitutes the valid and
legally  binding  obligations of the Company, enforceable in accordance with its
terms,  except  (i)  as  limited  by  applicable  bankruptcy,  insolvency,
reorganization,  moratorium,  and  other  laws  of general application affecting
enforcement of creditors' rights generally, and (ii) as limited by laws relating
to  the  availability  of  specific  performance,  injunctive  relief,  or other
equitable  remedies.

     2.5    Valid Issuance of Common Stock. The Series B Preferred Stock that is
the  subject of this Agreement, if issued, sold and delivered in accordance with
the terms of this Agreement for the consideration expressed herein, will be duly
and  validly  issued,  fully  paid,  and  nonassessable,  and  will  be  free of
restrictions  on  transfer  other than under this Agreement and applicable state
and  federal  securities laws.  The Common Stock issuable upon conversion of the
Series  B  Preferred  Stock  that may be purchased under this Agreement has been
duly  and  validly  reserved  for  issuance  and, upon issuance will be duly and
validly  issued,  fully paid, and nonassessable and will be free of restrictions
on  transfer  other than restrictions on transfer under this Agreement and under
applicable  state  and  federal  securities  laws.

     2.6     Consents.  Except for the consent of the holders of the Series A
Preferred  Stock,  no  consent,  approval,  order  or  authorization  of,  or
registration,  qualification,  designation,  declaration  or  filing  with,  any
federal, state or local governmental authority or any third party on the part of
the  Company is required in connection with the consummation of the transactions
contemplated  by  this Agreement, except any Blue Sky requirements or such other
post-closing  filings  as  may  be required. For avoidance of doubt, the parties
agree that the Company shall use its best efforts to obtain the consent required
under  the  Series  A  Investors'  Rights  Agreement for entering the Investor's
Rights  Agreement,  but  failure  to  obtain that consent shall not constitute a
breach  by  the Company of any representation, warranty or covenant contained in
this  Agreement.

<PAGE>

     2.7   Offering. Subject in part to the truth and accuracy of the Investor's
representations  set  forth  in Section 3 of this Agreement, the offer, sale and
issuance  of  the Series B Preferred Stock as contemplated by this Agreement and
the  Common  Stock issuable upon conversion of the Series B Preferred Stock will
be exempt from the registration requirements of any applicable state and federal
securities  laws, and neither the Company nor any authorized agent acting on its
behalf  will  take  any  action  hereafter  that  would  cause  the loss of such
exemption.

     2.8   Compliance with Other Instruments. The Company is not in violation or
default  of  any  provision  of  its  Certificate  or Bylaws, or in any material
respect  of  any  instrument,,  order, writ, decree or contract to which it is a
party  or  by  which it is bound, or, to the best of the Company's knowledge, of
any  provision of any federal or state statute, rule or regulation applicable to
the  Company.  The execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated hereby will not result in any such
violation  or  be in conflict with or constitute, with or without the passage of
time  and  giving  of  notice,  either  a  default  under  any  such  provision,
instrument,  judgment,  order, writ, decree or contract or an event that results
in  the  creation  of  any  lien,  charge  or encumbrance upon any assets of the
Company  or the suspension, revocation, impairment, forfeiture, or nonrenewal of
any  material  permit,  license,  authorization,  or  approval applicable to the
Company,  its  business  or  operations  or  any  of  its  assets or properties.

     2.9     Registration Rights.  Except as contemplated by this  Agreement and
provided  in  the agreements listed in Schedule 2.9, the Company has not granted
or  agreed  to grant any registration rights, including piggyback rights, to any
person  or  entity.

     2.10     Corporate  Documents.  The Certificate of Incorporation and Bylaws
of  the  Company  are  in  the  form  attached  hereto  as  Exhibits  C  and  D,
respectively.

     2.11     Litigation.  Except  as  set  forth  on Schedule 2.11, there is no
action,  suit,  proceeding  or  investigation  pending  or,  to  the  Company's
knowledge,  currently threatened against the Company that questions the validity
of this Agreement, or the right of the Company to enter into this Agreement, the
Investor's Rights Agreement (as defined below in Section 4(b)), or to consummate
the  transactions  contemplated hereby or that might result, either individually
or in the aggregate, in any material adverse changes in the assets, condition or
affairs  of  the Company, financially or otherwise, or any change in the current
equity  ownership  of  the  Company,  nor is the Company aware that there is any
basis  for  the foregoing.  The foregoing includes, without limitation, actions,
suits,  proceedings  or  investigations  pending  or  threatened  (or  any basis
therefor  known  to  the  Company)  involving the prior employment of any of the
Company's  employees, their use in connection with the Company's business of any
information  or  techniques  allegedly  proprietary  to  any  of  their  former
employers,  or their obligations under any agreements with prior employers.  The
Company  is  not  a  party  or  subject  to  the  provisions of any order, writ,
injunction,  judgment  or  decree  of  any  court  or  government  agency  or
instrumentality.  There  is  no action, suit, proceeding or investigation by the
Company  currently  pending  or  that  the  Company  intends  to  initiate.

<PAGE>

     2.12     Patents and Trademarks.  Except as set forth on Schedule 2.12, the
Company  or  its  subsidiaries  has  sufficient  title  and  ownership  of  all
copyrights,  trade  secrets,  information,  proprietary  rights  and  processes
necessary  for  its  business  as  now  conducted  without  any conflict with or
infringement  of  the  rights  of others.  Except as set forth on Schedule 2.12,
there  are  no outstanding options, licenses, or agreements of any kind relating
to  the  foregoing,  nor  is  the  Company  bound  by or a party to any options,
licenses  or  agreements  of  any  kind  with  respect  to the copyrights, trade
secrets,  licenses,  information,  proprietary rights and processes of any other
person or entity.  The Company has not received any communications alleging that
the  Company  has  violated any of the patents, trademarks, service marks, trade
names,  copyrights  or  trade  secrets  or other proprietary rights of any other
person  or entity.  Neither the execution nor delivery of this Agreement and the
Investor's Rights Agreement nor the carrying on of the Company's business by the
employees of the Company, nor the conduct of the Company's business will, to the
Company's  knowledge,  conflict  with  or  result  in  a  breach  of  the terms,
conditions  or  provisions  of,  or  constitute  a  default under, any contract,
covenant  or  instrument  under  which  any  of such employees is now obligated.

     2.13     Agreements;  Actions.

(a)     Except  as  set forth on Schedule 2.13(a) and except for agreements
explicitly contemplated hereby, including the Investor's Rights Agreement, there
are  no  agreements, understandings or proposed transactions between the Company
and  any  of  its  officers,  directors,  affiliates,  or any affiliate thereof;

(b)     Except  as  set forth on Schedule 2.13(b), there are no agreements,
understandings,  instruments,  contracts,  proposed  transactions,  judgments,
orders, writs or decrees to which the Company is a party or by which it is bound
that  may  involve  obligations (contingent or otherwise) of, or payments to the
Company  in  excess  of,  $50,000.

(c)     Except  as  set  forth  on  Schedule  2.13(c),  the  Company has not (i)
declared  or  paid  any dividends or authorized or made any distribution upon or
with  respect  to  any  class  or series of its capital stock, (ii) incurred any
indebtedness  for  money  borrowed  or  any  other liabilities (other than trade
liabilities  incurred in the ordinary course of business) individually in excess
of $100,000 or, in the case of indebtedness and/or liabilities individually less
than  $100,000,  in excess of $250,000 in the aggregate, (iii) made any loans or
advances  to any person, or (iv) sold, exchanged or otherwise disposed of any of
its  assets  or  rights  except  sales  of  inventory  in the ordinary course of
business.

     2.14     Related-Party Transactions.  Except as set forth on Schedule 2.14,
no employee, officer, director or stockholder of the Company or member of his or
her  immediate  family  or any entity controlled by any of them (each a "Related
Party") is indebted to the Company, nor is the Company indebted (or committed to
make loans or extend or guarantee credit) to any Related Party; no Related Party
has  any  direct  or indirect ownership interest in any firm or corporation with
which  the  Company  is  affiliated  or  with  which  the Company has a business
relationship,  or any firm or corporation that competes with the Company, and no
Related Party is directly or indirectly interested in any material contract with
the  Company.

     2.15     Permits.  Except  as  set  forth on Schedule 2.15, the Company has
all  franchises,  permits, licenses, and any similar authority necessary for the
conduct  of  its  business as now being conducted by it, the lack of which could
materially  and adversely affect the business, properties or financial condition
of the Company.  The Company is not in default in any material respect under any
of  such  franchises,  permits,  licenses,  or  other  similar  authority.

<PAGE>

     2.16     Environmental and Safety Laws.  The Company  is  not  in  material
violation  of  any  applicable  statute,  law  or  regulation  relating  to  the
environment  or occupational health and safety, and no material expenditures are
or  will  be  required in order to comply with any such existing statute, law or
regulation.

     2.17    Title to Property and Assets. Except as set forth on Schedule 2.17,
the Company owns its property and assets free and clear of all mortgages, liens,
loans  and  encumbrances.

     2.18     Employee Benefit Plans.  Except as set forth on Schedule 2.18, the
Company  does  not currently maintain any "employee benefit plan," as defined in
the  Employee  Retirement  Income  Security  Act  of  1974.

     2.19     Minute  Books.  The  minutes  of  the  Company  contain a complete
summary  of  all  meetings  of  directors  and  stockholders  since  the time of
incorporation  and  reflect  all  transactions  referred  to  in  such  minutes
accurately  in  all  material  respects.

     2.20     Disclosure.  The  Company has fully provided the Investor with all
the  information that the Investor has requested in deciding whether to purchase
the  Series  B  Preferred  Stock.  Neither this Agreement, the Investor's Rights
Agreement  nor  any  other  statements  or  certificates  made  or  delivered in
connection herewith contains any untrue statement of a material fact or omits to
state  a  material  fact  necessary to make the statements herein or therein not
misleading  in  light  of  the  circumstances  under  which  they  were  made.

     3.     Representations and Warranties of the Investor.  The Investor hereby
represents  and  warrants  that:

     3.1     Authorization.  The  Investor has full power and authority to enter
into this Agreement, and the Agreement constitutes its valid and legally binding
obligations,  enforceable  in accordance with its terms except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of
general  application  affecting  enforcement of creditors' rights generally, and
(ii)  as  limited  by laws relating to the availability of specific performance,
injunctive  relief,  or  other  equitable  remedies.

     3.2     Purchase Entirely for Own Account.  This Agreement is made with the
Investor  in  reliance  upon  its  representation  to  the Company, which by the
Investor's  execution  of  this  Agreement it hereby confirms, that the Series B
Preferred  Stock  that to be purchased by the Investor and the Common Stock that
would  be  issuable  upon  conversion  and  exercise  thereof  (collectively
"Securities") would be acquired for the Investor's own account, not as a nominee
or agent, and not with a view to the resale or distribution of any part thereof,
and  that  the  Investor  has  no  present  intention  of  selling, granting any
participation  in,  or  otherwise  distributing  the  same.  By  executing  this
Agreement,  the  Investor further represents that it does not have any contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant
participation's  to  such  person or to any third person, with respect to any of
the  Securities.

<PAGE>

     3.3     Investment Experience. The Investor acknowledges that it is able to
fend  for  itself,  can  bear  the economic risk of its investment, and has such
knowledge  and experience in financial or business matters that it is capable of
evaluating  the  merits  and  risks  of the investment in the Series B Preferred
Stock.

     3.4    Accredited Investor. The Investor is an "Accredited Investor" within
the meaning of Securities and Exchange Commission ("SEC") Rule 501 of Regulation
D,  as  presently  in  effect.

     3.5  Restricted Securities. The Investor understands that any Securities to
be  purchased  pursuant  to  this  Agreement  are  characterized  as "restricted
securities" under the federal securities laws inasmuch as they would be acquired
from the Company in a transaction not involving a public offering and that under
such  laws  and  applicable  regulations  such  securities may be resold without
registration  under  the  Act  only  in  certain limited circumstances.  In this
connection,  the  Investor  represents that it is familiar with SEC Rule 144, as
presently  in effect, and understands the resale limitations imposed thereby and
by  the  Act.

     3.6     Further Limitations on Disposition. Without in any way limiting the
representations  set  forth  above,  the Investor further agrees not to make any
disposition  of  all  or  any  portion  of  the  Securities unless and until the
transferee  has  agreed in writing for the benefit of the Company to be bound by
this  Section  3  and provided and to the extent this Section and such Agreement
are  then  applicable,  and:

(a)     There  is  then  in  effect  a registration statement under the Act
covering  such  proposed  disposition and such disposition is made in accordance
with  such  registration  statement;  or

(b)     (i)  The  Investor  shall have notified the Company of the proposed
disposition  and  shall  have furnished the Company with a detailed statement of
the  circumstances  surrounding the proposed disposition, and (ii) if reasonably
requested  by the Company, the Investor shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company that such disposition
will  not  require registration of such shares under the Act.  It is agreed that
the  Company will not require opinions of counsel for transactions made pursuant
to  Rule  144  except  in  unusual  circumstances.

(c)     Notwithstanding  the provisions of Paragraphs (a) and (b) above, no such
registration  statement  or opinion of counsel shall be necessary for a transfer
by  the  Investor  to  an  affiliate  (as defined in the Act), if the transferee
agrees in writing to be subject to the terms hereof to the same extent as if he,
she  or  it  were  the  Investor.

(d)     Legends.  It  is  understood  that  the  certificates  evidencing  the
Securities  that  may  be  issued  under  this  Agreement may bear the following
legends:

<PAGE>

"THESE  SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED.  THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE
ABSENCE  OF  A  REGISTRATION  STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES
UNDER  SUCH  ACT  OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH
REGISTRATION  IS  NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT."

     4.     Conditions of Investor's Obligations at Closing.  The obligations of
the  Investor  under this Agreement are subject to the fulfillment (or waiver by
the  Investor)  on  or  before  the Closing of each of the following conditions:

(a)     Representations and Warranties.  The representations and warranties
of  the  Company  contained  in Section 2 shall be true on and as of the Closing
with the same effect as though such representations and warranties had been made
on  and  as  of  the  date  of  the  Closing. The Investor shall have received a
certificate  executed  by  the Chief Executive Officer of the Company confirming
that  the  conditions  set forth in the immediately preceding sentence have been
satisfied.

(b)     Investor's  Rights  Agreement.  The  Company and the Investor shall
have  entered  into  the  Investor's  Rights Agreement substantially in the form
attached  as  Exhibit  B  (the  "Investor's  Rights  Agreement"), subject to the
Company  having  obtained  the  consent  required  under  the  Investors' Rights
Agreement  dated  March  20,  2000 (the "Series A Investors' Rights Agreement").

(c)     Consents.  All  required stockholder consents or approvals shall be duly
obtained  and  effective as of the Closing.  For avoidance of doubt, the parties
agree that the Company shall use its best efforts to obtain the consent required
under  the  Series  A  Investors'  Rights  Agreement for entering the Investor's
Rights  Agreement,  but  failure  to  obtain that consent shall not constitute a
breach  by  the Company of any representation, warranty or covenant contained in
this  Agreement.

(d)     Due  Diligence.  The  Investor  shall have completed to its satisfaction
its  business, legal and accounting due diligence concerning the Company.  It is
hereby  agreed  and  understood  that, if the Investor is not satisfied with the
results  of  its  due  diligence efforts for any reason whatsoever, the Investor
may,  in  its  sole  discretion,  determine  not  to consummate the transactions
contemplated hereby and such failure to consummate shall not constitute a breach
by  the  Investor of any provision of this Agreement.  The Investor shall notify
the  Company immediately of any determination not to consummate the transactions
contemplated  hereby.

(e)     If  the  merger pursuant to the Agreement between Sensar Corporation and
the  Company  dated  December  8, 1999 is not yet consummated, the Company shall
have  filed  a  Certificate  of  Designation for the Series B Preferred Stock in
substantially  the  form  attached  hereto  as  Exhibit A with the Office of the
Secretary  of  State  of  the  State  of  Delaware.

<PAGE>

     5.     Conditions of the Company's Obligations at Closing.  The obligations
of the Company under this Agreement are subject to the fulfillment (or waiver by
the  Company)  on  or  before  the  Closing of each of the following conditions:

(a)     Representations and Warranties.  The representations and warranties
of  the  Investor  contained in Section 3 shall be true on and as of the Closing
with the same effect as though such representations and warranties had been made
on  and  as  of  the  date  of  the  Closing.  The Company shall have received a
certificate  executed  by a senior  executive officer of the Investor confirming
that  the  conditions  set forth in the immediately preceding sentence have been
satisfied.

(b)     Consents.  All required consents or approvals to be obtained by the
Investor  will  be  duly  obtained  and  effective  as  of  the  Closing.

     6.     Miscellaneous.

     6.1     Indemnification.

(a)     The  Company  shall indemnify, defend and hold the Investor and its
employees,  officers,  directors,  shareholders,  affiliates and agents harmless
against  all  liability,  loss or damage, together with all reasonable costs and
expenses related thereto (including reasonable legal fees and expenses) relating
to  or  rising  from  the  untruth,  inaccuracy  or  breach  of  any  of  the
representations,  warranties  or  agreements  of  the  Company contained in this
Agreement.

(b)     The  Investor  shall indemnify, defend and hold the Company and its
employees,  officers,  directors,  shareholders,  affiliates and agents harmless
against  all  liability,  loss or damage, together with all reasonable costs and
expenses related thereto (including reasonable legal fees and expenses) relating
to  or  rising  from  the  untruth,  inaccuracy  or  breach  of  any  of  the
representations,  warranties  or  agreements  of  the Investor contained in this
Agreement.

(c)     The  indemnification  provided  for  under this Agreement will remain in
full  force  and  effect regardless of any investigation made by or on behalf of
the  indemnified  party  or  any  officer, director or controlling person of the
indemnified  party  and  will  survive  the  transfer  of  securities.

     6.2     Survival  of  Warranties.  The  warranties,  representations  and
covenants  of  the  Company and of the Investor contained in or made pursuant to
this  Agreement  shall  survive the execution and delivery of this Agreement for
twelve  (12)  months and shall in no way be affected by any investigation of the
subject  matter  thereof  made  by  or on behalf of the Investor or the Company.

     6.3     Successors  and  Assigns.  Except as otherwise provided herein, the
terms  and  conditions  of  this  Agreement shall inure to the benefit of and be
binding  upon  the  respective  successors and assigns of the parties (including
transferees  of  the  Series  B  Preferred Stock or the Common Stock issued upon
conversion of the Series B Preferred Stock).  Nothing in this Agreement, express
or  implied,  is intended to confer upon any party other than the parties hereto
or their respective successors and assigns any rights, remedies, obligations, or
liabilities  under  or by reason of this Agreement, except as expressly provided
in  this Agreement. Notwithstanding any provision to the contrary and subject to
Section 3.6 hereof the Investor shall have the right to assign any or all of its
rights  under  this  Agreement  or  transfer the securities to an "affiliate" as
defined  in  the  Act.

<PAGE>

     6.4     Governing  Law.  This Agreement shall be governed by and construed
under the laws of the state of Delaware as applied to agreements among Delaware
residents  entered  into  and  to  be  performed  entirely  within  Delaware.

     6.5     Counterparts.  This  Agreement may be executed in two counterparts,
each of which shall be deemed an original, but  both  of  which together shall
constitute  one  and  the  same  instrument.

     6.6     Titles  and  Subtitles.  The titles and subtitles used in this
Agreement are  used  for  convenience  only  and are not to be considered in
construing or interpreting  this  Agreement.

     6.7     Notices.  Unless  otherwise  provided,  any  notice  required  or
permitted  under  this  Agreement  shall be given in writing and shall be deemed
effectively  given  upon  personal  delivery to the party to be notified or upon
deposit  with  the United States Post Office, by registered or certified mail or
overnight  courier, postage prepaid and addressed to the party to be notified at
the  address  indicated  for such party on the signature page hereof, or at such
other  address  as  such  party  may designate by ten (10) days' advance written
notice  to  the  other  parties.

     6.8     Finder's Fee.  Each party represents that it neither is nor will be
obligated  for  any  finders'  fee  or  commission  in  connection  with  this
transaction.  The  Investor agrees to indemnify and to hold harmless the Company
from  any  liability  for  any  commission  or  compensation  in the nature of a
finders'  fee (and the costs and expenses of defending against such liability or
asserted  liability)  for  which  the Investor or any of its officers, partners,
employees,  or  representatives  is  responsible.

     The  Company  agrees  to  indemnify and hold harmless the Investor from any
liability  for  any  commission  or compensation in the nature of a finders' fee
(and  the  costs  and  expenses  of defending against such liability or asserted
liability),  for  which  the  Company  or  any  of  its  officers,  employees or
representatives  is  responsible.

     6.9     Expenses.  Each  of  the  parties  shall  bear its respective costs
associated  with  this  Agreement  and  the  transactions  contemplated  hereby,
including  legal  fees,  accounting  fees,  and  other  costs  and  expenses.

     6.10     Severability.  If  one  or  more  provisions of this Agreement are
held  to be unenforceable under applicable law, such provision shall be excluded
from  this Agreement and the balance of the Agreement shall be interpreted as if
such  provision were so excluded and shall be enforceable in accordance with its
terms.

     6.11     Entire Agreement.  This Agreement and the documents referred to
herein constitute  the  entire agreement among the parties and no party shall be
liable or bound to any other party in any manner by any warranties,
representations, or covenants except as specifically set forth herein or
therein.

<PAGE>

IN  WITNESS  WHEREOF,  the  parties  have executed this Agreement as of the date
first  above  written.

COMPANY:

NET2WIRELESS CORPORATION

By:  /s/
   Title: Chief Executive Officer
   Address:

INVESTOR:

NEXTEL FINANCE COMPANY

By:  /s/
   Title:
   Address:

<PAGE>

                                    Exhibit A
                           Certificate of Designation

<PAGE>

                                    Exhibit B
                           Investor's Rights Agreement

<PAGE>

                                    Exhibit C
                          Certificate of Incorporation

<PAGE>

                                    Exhibit D
                                     Bylaws

<PAGE>

                                 Schedule 2.2(c)

Name of Entity                   Number of Shares of
                                    Common Stock

Cedar Investment Services Ltd.         5,428,127
Nova Business Services Corp.             515,608
Oryon BVI                                  4,286
Benjamin Levin                             4,286
Paul Croitoroo                             4,286
Yossef Benaksas                            4,286
Gabriel Schreiber                          1,071
Ben-Zion Weiner                            6,429
Janon Holdings B.V.                        2,857
Aharon Livnat                              3,571
Elizabeth Toronczyk                        4,179
Rephael Fozailoff                          1,607
Issac Tepper                                 643
Meridian Trading Investment Ltd.         779,154
Ultimate Business Management Ltd.         78,010
Ring Trading Ltd.                        337,798
Fogel Michael                             92,800
Silk Investments Ltd.                     92,800
Ruhe Enterprises Inc.                    680,533
Ednir Holdings Ltd.                      185,600
Zetto Investments S.A.                   123,733
Renana Meller                             61,866
Acme Investments Ltd.                     61,866
Genine Fan                               123,733
Eli Katz                                 123,733
Alexander/Rachel LLC                   1,862,249
NDBD LLC                               1,862,249
Yitzchak Bachar on behalf of a
   company in foundation                 696,265
CYE 2000 LLC                             130,665
Shor Yoshuv Institute                     52,267
Aaron Fischel                             26,133
Aaron Kotler                              26,133
Harvey Augenbaum                          26,133
S.A.C. Capital Associates, LLC           143,210
Aeneas Portfolio Company, L.P.           214,815
Elkanit Development Ltd.
   (on behalf of itself and some
   of its subsidiaries)                  179,016
Orland Investment Inc.                    53,704
Waine Saker & Peter Grabler               35,802
Kairos Fund Limited                      161,111
Janon Holdings B.V                        71,605
Y.A.Z Investment Assets                   12,889
Pinsk Assets                              12,889
Yehuda Tzadik                             12,889
Banque Multi Commerciale                  38,667
Apex Investments                          10,741
Menora Financial Corp.                    15,307
Churchill Consulting & Development Co.    71,605
Richard Jacobs                             3,580
Jeffrey Robert                             3,580

<PAGE>

                                 Schedule 2.2(e)

The Stockholders Agreement dated March 20, 2000;

     The  Investors'  Rights  Agreement  dated  March  20,  2000.

<PAGE>

                                  Schedule 2.9

(i) The Partner Agreement;

(ii) A warrant issued to ML Partners LLC;

(iii) An agreement signed on February 2, 2000, between the Company and Berkman
Wechsler-Limited Partnership, under which options for purchase of 68,741 shares
of Common Stock were granted;

(iv) The Agreement signed among the Company and some of its stockholders on
January 17, 2000;

(v) The Investors' Rights Agreement dated March 20, 2000

(vi) An option agreement signed on between the Company and Mr. David Rubner, the
Chairman of the Board of directors

(vii) An option agreement signed on March 20, 2000, between the Company and
Beneficial Investment Services Ltd., an entity controlled by Mr. Joav Avtalion,
director of the Company

(viii) An option agreement signed between the Company and Meridian Trading
Investment Ltd. on March 20, 2000

(ix) A Consultation Agreement signed between the Company and Mr. Tim Price. on
April 1, 2000.
<PAGE>FIRST AMENDMENT TO CREDIT AGREEMENT

         THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this "Amendment") is made the
24th day of  March,  2000,  between  ATLANTIC  AMERICAN  CORPORATION,  a Georgia
corporation (the "Borrower") and WACHOVIA BANK, N.A (the "Bank").

                                  Background:
                                  ----------

         The Borrower and the Bank have entered into a Credit Agreement dated as
of July 1, 1999 (the  "Credit  Agreement").  The  Borrower  and the Bank wish to
amend the Credit Agreement in certain respects, as hereinafter provided.

         NOW, THEREFORE, the Borrower and the Bank agree as follows:

         SECTION 1.      Definitions.  Capitalized  terms  used  herein  which
                         are not  otherwise  defined  herein  shall  have  the
                         respective meanings assigned to them in the Credit
                         Agreement.

         SECTION 2.      The Credit Agreement is amended as set forth in this
                         Section 2.

         2.1.  Amendment to Section  1.01.  Section 1.01 of the Credit
                --------------------------  Agreement is hereby  amended by
                                            inserting a new  definition  to
                                            read as follows:

                "Effective Date" means March 24, 2000.

         2.2.  Amendment to Section 2.05.  Section  2.05(a) of the Credit
             -------------------------     Agreement is hereby  amended and
                                           restated in its entirety to
                                           read as follows:

               (a)"Applicable  Margin"  shall be determined  quarterly  based
                upon the ratio of Funded Debt to EBITDA  (calculated as of the
                last day of each Fiscal Quarter), as follows:

        Ratio of Funded Debt to EBITDA      Base Rate Loans   Euro-Dollar Loans
        ------------------------------      ---------------   -----------------
        Greater than or equal to 5.5 to 1.0       0%                3.75%

        Greater than or equal to 5.0 to 1.0
        but less than  5.5 to 1.0                 0%                3.25%

        Greater than or equal to 4.5 to 1.0
        but less than 5.0 to 1.0                  0%                2.75%

        Greater than or equal to 4.0 to 1.0
        but less than  4.5 to 1.0                 0%                2.50%

        Greater than or equal to 3.5 to 1.0
        but less than 4.0 to 1.0                  0%                2.25%

        Greater than or equal to 3.0 to 1.0
        but less than 3.5 to 1.0                  0%                2.00%

        Less than 3.0 to 1.0                      0%                1.75%

         The  Applicable  Margin  shall be  determined  effective as of the date
         (herein, the "Rate Determination Date") which is 60 days after the last
         day of the Fiscal Quarter as of the end of which the foregoing ratio is
         being determined,  based on the quarterly  financial  statements of the
         Borrower  for  such  Fiscal  Quarter,  and  the  Applicable  Margin  so
         determined  shall remain  effective from such Rate  Determination  Date
         until  the date  which  is 60 days  after  the  last day of the  Fiscal
         Quarter in which such Rate  Determination Date falls (which latter date
         shall  be a new Rate  Determination  Date);  provided  that (i) for the
         period from and including the Effective  Date to but excluding the

<PAGE>
         Rate Determination Date next following the Effective Date, the
         Applicable Margin shall be 0% for Base Rate Loans and 3.25% for Euro-
         Dollar Loans (ii) in the case of any Applicable Margin determined for
         the fourth and final Fiscal  Quarter of a Fiscal  Year, the Rate
         Determination  Date shall be the date  which is 120 days  after the
         last day of such final Fiscal Quarter and such  Applicable Margin shall
         be determined based upon the annual  audited  financial  statements of
         the Borrower for the Fiscal Year ended on the last day of such final
         Fiscal Quarter, and (iii) if on any Rate  Determination Date the
         Borrower shall have failed to  deliver  to the  Banks  the  financial
         statements  required  to be delivered  pursuant to Section  5.01(a) or
         Section 5.01(b) with respect to the Fiscal Year or Fiscal Quarter, as
         the case may be, most recently ended  prior to such  Rate Determination
         Date, then for the period beginning on such Rate Determination Date and
         ending on the immediately succeeding  Rate  Determination  Date, the
         Applicable Margin shall be determined  as if the ratio of Funded  Debt
         to EBITDA was more than 5.5 to 1.0 at all times  during such period.
         Any change in the  Applicable Margin on any Rate  Determination  Date
         shall result in a corresponding change,  effective on and as of such
         Rate Determination  Date, in the interest  rate  applicable  to  each
         Loan  outstanding  on  such  Rate Determination  Date,  provided  that
         no  Applicable  Margin  shall  be decreased pursuant to this Section
         2.05 if a Default is in existence on the Rate Determination Date.

         2.3.  Amendment to Section 5.03.  Section 5.03 of the Credit  Agreement
         -------------------------------   is hereby amended and restated in its
                                           entirety to read as follows:

                  SECTION  5.03.  Ratio of  Funded  Debt to  Consolidated  Total
         Capitalization.   The  ratio  of  Funded  Debt  to  Consolidated  Total
         Capitalization  will not at any time exceed (i) for the period from and
         including the Effective  Date to and including  December 31, 2000,  50%
         and (ii) for any period on or after January 1, 2001, 40%.

         2.4.  Amendment to Section 5.05.  Section 5.05 of the Credit  Agreement
       ---------------------------------   is hereby amended and restated in its
                                           entirety to read as follows:

                  SECTION 5.05. Ratio of Funded Debt to EBITDA. As of the end of
         each  Fiscal  Quarter,  the ratio of Funded  Debt as of the end of such
         Fiscal  Quarter  to  EBITDA  for the  period  of 4  consecutive  Fiscal
         Quarters  then ended shall be less than (a) 5.85 to 1.0 for each Fiscal
         Quarter  ending on or before March 31,  2000,  (b) 5.10 to 1.0 for each
         Fiscal  Quarter  ending after March 31, 2000, and on or before June 30,
         2000,  (c) 4.35 to 1.0 for each Fiscal  Quarter  ending  after June 30,
         2000,  and on or before  December  31,  2000,  (d) 3.50 to 1.0 for each
         Fiscal  Quarter  ending  after  December  31,  2000,  and on or  before
         September  30,  2001,  and  (c)  3.00 to 1.0 for  each  Fiscal  Quarter
         thereafter.

         2.5.  Amendment to Section 5.06.  Section 5.06 of the Credit  Agreement
        ---------------------------------  is hereby amended and restated in its
                                           entirety to read as follows:

                  SECTION  5.06.  Ratio  of  EBITDA  to  Consolidated   Interest
         Expense. At the end of each Fiscal Quarter, the ratio of EBITDA for the
         period of 4  consecutive  Fiscal  Quarters  then ended to  Consolidated
         Interest  Expense for the period of 4 consecutive  Fiscal Quarters then
         ended  shall be  greater  than (a) 2.5 to 1.0 for each  Fiscal  Quarter
         ending  on or  before  June 30,  2000,  (b) 3.0 to 1.0 for each  Fiscal
         Quarter  ending on or before  June 30, 2001 and (c) 3.5 to 1.0 for each
         Fiscal Quarter thereafter.

         SECTION  3. No Other  Amendment.  Except  for the  amendment  set forth
above, the text of the Credit Agreement shall remain unchanged and in full force
and effect.  This Amendment is not intended to effect, nor shall it be construed
as, a novation.  The Credit  Agreement  and this  Amendment  shall be  construed
together as a single  instrument  and any  reference to the  "Agreement"  or any
other defined term for the Credit  Agreement in the Credit  Agreement,  the Loan
Documents or any certificate,  instrument or other document  delivered  pursuant
thereto  shall mean the  Credit  Agreement  as  amended  hereby and as it may be
amended,  supplemented or otherwise modified hereafter. Nothing herein contained
shall  waive,  annul,  vary or affect  any  provision,  condition,  covenant  or
agreement contained in the Credit Agreement, except as herein amended, or any of
the other Loan  Documents  nor affect nor impair any rights,  powers or remedies
under  the  Credit  Agreement,  as  hereby  amended  or any of  the  other  Loan
Documents.  The Bank does hereby reserve all of its rights and remedies  against
all  parties  who may be or may  hereafter  become  secondarily  liable  for the
repayment of the Notes.  The Borrower  promises and agrees to perform all of the
requirements,  conditions,  agreements  and  obligations  under the terms of the
Credit  Agreement,  as  heretofore  and  hereby  amended,  and  the  other  Loan
Documents,  the Credit Agreement, as amended, and the other Loan Documents being
hereby  ratified and affirmed.  The Borrower  hereby  expressly  agrees that the
Credit Agreement, as amended, and the other Loan Documents are in full force and
effect.

<PAGE>
         SECTION 4.  Representations and Warranties. The Borrower hereby
          ----------------------------------------   represents and warrants in
                                                   favor of the Bank as follows:

         (a)      The  representations  and warranties of the Borrower
                  contained in Article IV of the Credit Agreement are true on
                  and as of the date hereof;

         (b)      No Default or Event of Default under the Credit Agreement has
                  occurred and is continuing on the date hereof;

         (c) The Borrower has the  corporate  power and  authority to enter into
this  Amendment  and to do all acts and things as are  required or  contemplated
hereunder to be done, observed and performed by it;

         (d) This  Amendment  has been duly  authorized,  validly  executed  and
delivered by one or more authorized officers of the Borrower, and this Amendment
and the Credit  Agreement,  as amended hereby  constitutes the legal,  valid and
binding obligation of the Borrower enforceable against it in accordance with its
terms; and

         (e) The  execution and delivery of this  Amendment  and the  Borrower's
performance  hereunder and under the Credit  Agreement as amended  hereby do not
and will not require the consent or  approval  of any  regulatory  authority  or
governmental  authority or agency having  jurisdiction  over the Borrower  other
than those which have already been obtained or given, nor be in contravention of
or in conflict with the Articles of Incorporation or Bylaws of the Borrower,  or
the provision of any statute, or any judgment,  order or indenture,  instrument,
agreement  or  undertaking,  to which  the  Borrower  is a party or by which its
assets or properties are or may become bound.

         SECTION 5.  Counterparts.  This  Amendment  may be executed in multiple
                     ------------   counterparts,  each of which shall be deemed
                                    to be an original and all of which, taken
                                    together, shall constitute one and the same
                                    agreement.

         SECTION 6.  Governing  Law.  This  Amendment  shall be construed in
                     --------------   accordance  with and governed by the laws
                                      of the State of Georgia.

         SECTION 7.  Amendment  Fee. On the  Effective  Date, the Borrower shall
                  --------------     pay to the Bank an amendment fee equal to
                                     the product of the Commitment (irrespective
                                     of usage) as of such date multiplied by
                                     0.25%.

                        [Remainder of page intentionally left blank]

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
duly executed under seal by their respective  authorized  officers as of the day
and year first above written.

Attest:                                        ATLANTIC AMERICAN CORPORATION

_______________________________       By:________________________________(SEAL)

 Its:__________________________       Its: __________________________________

  [CORPORATE SEAL]

                                           WACHOVIA BANK, N.A.

                                      By:__________________________________
                                     Title:________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}]]